Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů

| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 20,63 | | | 228 | H01BB | oxytocin a jeho deriváty | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 44,28 | H | | 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | | | | | 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 19,80 | H | | 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | | | | | 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z | | 86238 | KRYPTOCUR | inh sol 1x10gm+pump | HOE | D | | | | | 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z | | | | | | | | | | | 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z | | 230 | H01CB | somatostatin a jeho deriváty | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 8052,52 | X | | 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B | | | | | 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | | | | | 83084 | SOMATOSTATIN 6MG | inj sic 1x6mg+solv. | UCB | B | | | | | 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5050,76 | X | | 93866 | SANDOSTATIN | inj 5x1ml/0.5mg | SAN | CH | | | | | 230.3 | H01CB03 | lantreotid | parent. | 2,14 | MG | 2206,74 | X | | 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | | | | | 231 | H02AA | mineralokortikoidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | | | 23865 | FLUDROCORTISON | tbl 100x0.1mg | SQH | D | | | | | 232 | H02AB | glukokortikoidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | | | | | | | | | | | | 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | | | 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | | | | | 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | | | 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ | | | | | 70508 | DEXONA | tbl 100x0.5mg | CAD | IND | | | | | 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | | | | | | | | | | | | 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | | | 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B | | | | | 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B | | | | | 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,49 | | | 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | | | | | 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | | | | | 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | | | 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ | | | | | 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | | | 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | | | | | 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | | | 80588 | CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH | | | | | 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | | | 84000 | RECTODELT | sup 6x5mg | TRM | D | | | | | 84001 | RECTODELT | sup 6x10mg | TRM | D | | | | | 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | | | 84003 | RECTODELT | sup 6x100mg | TRM | D | | | | | 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | | | 84002 | RECTODELT | sup 6x30mg | TRM | D | | | | | 233 | H02AB | glukokortikoidy | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O | | 02125 | DEPERSOLON | inj 3x1ml/30mg | GED | H | | | | | 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 4,01 | O | | 89870 | DIPROPHOS | inj 1x1ml | SCH | B | | | | | 78257 | DIPROPHOS | inj 5x1ml | SCH | F | | | | | 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 26,54 | O | | 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D | | | | | 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O | | 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | | | | | 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND | | | | | 96109 | DEXONA | inj 8x6x2ml | CAD | IND | | | | | 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 36.20 | O | | 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B | | | | | 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O | | | | | | | | | | | 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,44 | O | | 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B | | | | | 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O | | 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | | | | | 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O | | 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | | | | | 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O | | 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ | | | | | 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ | | | | | 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O | | 03950 | SOLU-CORTEF | inj sic 1x100mg | UPJ | B | | | | | 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B | | | | | 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ | | | | | 234 | H03AA | hormony štítné žlázy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | | | 61161 | JODTHYROX | tbl 100 | MEC | D | | | | | 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | | | 77584 | L-THYROXIN 50 BERLIN-CHEMIE | tbl 100x50rg | BCE | D | | | | | 62190 | EUTHYROX 50 | tbl 100x50rg | MEC | D | | | | | 47141 | LETROX 50 | tbl 100x50rg | BCE | D | | | | | 96142 | L-THYROXINE 50 HENNING | tbl 100x50rg | HNB | D | | | | | 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | | | 96146 | L-THYROXINE 100 HENNING | tbl 100x100rg | HNB | D | | | | | 47133 | LETROX 150 | tbl 100x150rg | BCE | D | | | | | 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | | | 96150 | L-THYROXINE 150 HENNING | tbl 100x150rg | HNB | D | | | | | 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,89 | | | 09805 | TERTROXIN | tbl 100x0.02mg | GLA | GB | | | | | 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | | | 03875 | THYREOTOM | tbl 60x50rg | BCE | D | | | | | 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,82 | | | 61158 | JODID 100 | tbl 100 | MEC | D | | | | | 61159 | JODID 200 | tbl 100 | MEC | D | | | | | 235 | H03B | thyreostatika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,92 | | | 09577 | PROPYCIL 50 | tbl 100x50mg | KCH | D | | | | | 09576 | PROPYCIL 50 | tbl 20x50mg | SVP | D | | | | | 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 2,83 | | | 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | | | | | 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,10 | | | | | | | | | | | | 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | | | 236 | H03B | thyreostatika | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H | | 20617 | FAVISTAN | inj 10x1ml/40mg | ASD | D | | | | | 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA | | 90511 | GLUCAGON | inj sic 1x10mg+sol | LIL | USA | | | | | 02392 | GLUCAGON | inj sic 1x1mg+sol | LIL | USA | | | | | 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA | | 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | | | | | 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 115,70 | L/INT,GYN,ORT, END | | | | | | | | | | | 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 115,70 | L/INT,GYN,ORT, END | | 56091 | MIACALCIC NASAL 200 | spr nas 1x2 ml | NPA | CH | | | | | 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,GYN,ORT, END | | 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B | | | | | 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,GYN,ORT, END | | | | | | | | | | | 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,GYN,ORT, END | | 240 | J01AA | tetracyklinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | | | 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ | | | | | 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | | | | | 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | | | | | 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | | | | | 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | | | | | 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | | | | | | | | | | | | 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | | | | | | | | | | | | 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | | | | | | | | | | | | 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | | | 241 | J01AA | tetracyklinová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K | | 94790 | VIBRAMYCIN | inj sic 1x200mg | PFI | B | | | | | 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | | | | | 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | | | | | 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K | | 242 | J01BA | amfenikolová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | | | 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | | | | | 243 | J01BA | amfenikolová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 241,12 | K | | 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | | | | | 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K | | 244 | J01CA | aminopenicilinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 16,62 | | | 60916 | AMPICILIN 250 LECIVA | cps 20x250mg | LEX | CZ | | | | | 60917 | AMPICILIN 250 LECIVA | cps 30x250mg | LEX | CZ | | | | | 60920 | AMPICILIN 500 LECIVA | cps 20x500mg | LEX | CZ | | | | | 60921 | AMPICILIN 500 LECIVA | cps 30x500mg | LEX | CZ | | | | | 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 20,24 | | | 84508 | AMPICILIN 250 LECIVA | sir sic 1x5gm/100ml | LEX | CZ | | | | | 244.3 | J01CA04 | amoxicilin (pevné lékové formy) | p.o. | 1 | GM | 10,12 | | | 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | | | | | 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | | | | | 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | | | | | 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | | | | | 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | | | | | 244.4 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | | | 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | | | | | 244.5 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,75 | | | | | | | | | | | | 244.6 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | | | 245 | J01CA | aminopenicilinová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K | | 60248 | PENTREXYL | inj sic 50x250mg | BMS | I | | | | | 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB | | 04035 | SECUROPEN | inj sic 5x2gm+20ml | BAY | D | | | | | 97002 | SECUROPEN | inf 5x5gm | BAY | D | | | | | 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB | | 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR | | | | | 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB | | 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 ku v jedné tabletě) | p.o. | 2 | GM | 19,65 | | | 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | | | | | 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | | | | | 69468 | PENBENE | tbl obd 30x1mu | MCK | D | | | | | 69467 | PENICILLIN V 1 MEGA VON CT | tbl obd 10x1mu | CTA | D | | | | | 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | | | | | 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | | | | | 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 ku v jedné tabletě) | p.o. | 2 | GM | 21,02 | | | 84626 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-lekov. | SLO | SK | | | | | 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | | | | | 247.3 | J01CE02 | fenoxymethylpenicilin ( od 500 ku včetně do 900 ku včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | | | 84627 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-lekov. | SLO | SK | | | | | 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | | | | | 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14,52 | | | 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | | | | | 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | | | 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | | | | | 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | | | 98281 | INFECTOCILLIN 250 SIRUP | gra sus 1x75ml | INF | D | | | | | 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 kIU v 5 ml) | p.o. | 2 | GM | 26,30 | | | 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K | | 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | | | | | 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K | | 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | | | | | 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.0 | MU | 70,63 | K | | 01089 | PENDEPON | inj 10x600ku | BTA | SK | | | | | 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.0 | MU | 32,94 | K | | 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A | | | | | 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K | | 01101 | PROKAIN PENICILIN G BIOTIKA | inj 10x600ku | BTA | SK | | | | | 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K | | 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | | | | | 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K | | 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | | | | | 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | | | | | | | | | | 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | | | | | | | | | | 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | | | 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ | | | | | 60247 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | I | | | | | 60437 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | USA | | | | | 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | | | 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K | | 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | | | | | 92357 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | I | | | | | 60243 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | USA | | | | | 92358 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | I | | | | | 60245 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | USA | | | | | 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 251.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy (pevné lékové formy) | p.o. | 1.5 | GM | 92,87 | | | | | | | | | | | | 251.2 | J01CR01 | ampicilin a inhibitor beta-laktamázy (tekuté lékové formy) | p.o. | 1.5 | GM | 112,42 | | | | | | | | | | | | 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 40,81 | | | | | | | | | | | | 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 37,15 | | | | | | | | | | | | 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 34,85 | | | | | | | | | | | | 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 50,74 | | | | | | | | | | | | 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 39,89 | | | 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO | | | | | 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 1,5 | GM | 158,37 | U/ATB | | | | | | | | | | | 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 110,42 | U/ATB | | 97659 | AUGMENTIN I.V. | inj 10x600mg | LEX | CZ | | | | | 97660 | AUGMENTIN I.V. | inj 5x1.2gm | LEX | CZ | | | | | 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | | | | | 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | | | | | 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB | | | | | | | | | | | 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB | | | | | | | | | | | 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U | | | | | | | | | | | 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB | | 253 | J01DA | cefalosporinová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | | | 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | | | | | 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D | | | | | 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D | | | | | 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D | | | | | 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D | | | | | 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | | | | | 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | | | | | 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | | | 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | | | | | 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | | | | | 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 114,38 | | | | | | | | | | | | 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | | | | | | | | | | | | 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 95,80 | | | 56962 | CECLOR | cps 21x250mg | LIL | CH | | | | | 99231 | CECLOR | cps 15x250mg | LIL | CH | | | | | 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I | | | | | 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND | | | | | 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 129,04 | | | 99217 | CECLOR | sus 75ml 125mg/5ml | LIL | CH | | | | | 99221 | CECLOR | sus 75ml 125mg/5ml | LIL | I | | | | | 53151 | VERCEF125 MG/5ML | plv sus 1x100 ml | RXY | IND | | | | | 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 118,29 | | | 99222 | CECLOR | sus 75ml 250mg/5ml | LIL | CH | | | | | 99226 | CECLOR | sus 75ml 250mg/5ml | LIL | I | | | | | 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND | | | | | 253.8 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 50,25 | | | 93905 | DURACEF | cps 12x500mg | BRI | I | | | | | 253.9 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 73,86 | | | | | | | | | | | | 253.10 | J01DA23 | cefixim | p.o. | 0.4 | GM | 113,01 | ATB | | 76235 | SUPRAX | plv sus 1x50ml/1gm | GED | H | | | | | 76233 | SUPRAX | tbl obd 10x200mg | GED | H | | | | | 253.11 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB | | | | | | | | | | | 253.12 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 114,38 | ATB | | | | | | | | | | | 253.13 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 114,38 | ATB | | | | | | | | | | | 253.14 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 92,87 | | | 56963 | CECLOR | cps 21x500mg | LIL | CH | | | | | 99240 | CECLOR | cps 15x500mg | LIL | CH | | | | | 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND | | | | | 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:

• a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,

• b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),

• c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).

| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U | | 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | | | | | 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 180,07 | U | | 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND | | | | | 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK | | | | | 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK | | | | | 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB | | | | | | | | | | | 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 497,69 | U/ATB | | 76360 | ZINACEF AD INJ. | inj sic 1x1.5gm | GLA | I | | | | | 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 663,29 | U/ATB | | 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | | | | | 254.7 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB | | | | | | | | | | | 254.8 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.9 | J01DA13 | ceftriaxon | parent. | 2 | GM | 769,55 | ambulantně: K/P ústavně: U/ATB | | 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | | | | | 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO | | | | | 254.10 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB | | | | | | | | | | | 254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U | | | | | | | | | | | 254.12 | J01DA32 | cefoperazon | parent. | 6 | GM | 1795,57 | U/ATB | | 75039 | CEFOBID | inj sic 1x1gm | PFI | TR | | | | | 254.13 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB | | 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | | | | | 254.14 | J01DA24 | cefepim | parent. | 4 | GM | 1690,43 | U/ATB | | | | | | | | | | | 254.15 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 593,68 | U/ATB | | | | | | | | | | | 254.16 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB | | 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1694,73 | U/ATB | | 86412 | AZACTAM | inj sic 1x1gm | BMS | I | | | | | 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB | | 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB | | | | | 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB | | 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | | | 62325 | TRIPRIM 100MG | tbl 10x100mg | MCK | A | | | | | 76513 | TRIPRIM 100MG | tbl 20x100mg | MCK | A | | | | | 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | | | 62324 | TRIPRIM 200MG | tbl 10x200mg | MCK | A | | | | | 76510 | TRIPRIM 200MG | tbl 20x200mg | MCK | A | | | | | 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | | | 00313 | SULFISOXAZOL LECIVA | tbl 20x500mg-blistr | LEX | CZ | | | | | 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | | | | | | | | | | | | 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | | | 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND | | | | | 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND | | | | | 06264 | SUMETROLIM | tbl 20x480mg | EGI | H | | | | | 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | | | 75459 | PRIMOTREN | sus 1x100ml | LEK | SLO | | | | | 87757 | ORIPRIM PRO INFANT. | sus 50ml 240mg/5ml | CAD | IND | | | | | 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | | | | | | | | | | 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | | | | | | | | | | | | 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | | | 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 113,40 | K | | 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | | | | | 260 | J01FA | makrolidová antibiotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | | | 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | | | 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D | | | | | 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | | | | | 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | | | | | 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | | | | | 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 67,26 | | | | | | | | | | | | 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 19,21 | | | | | | | | | | | | 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 48,63 | | | 65367 | RULID 100MG | tbl obd 10x100mg | LEX | CZ | | | | | 65366 | RULID 50MG | tbl obd 10x50mg | LEX | CZ | | | | | 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 42,04 | | | 96452 | RULID 150MG | tbl obd 20x150mg | LEX | CZ | | | | | 55467 | RULID 300MG | tbl obd 10x300mg | LEX | CZ | | | | | 96731 | RULID 150MG | tbl obd 10x150mg | LEX | CZ | | | | | 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 42,04 | | | | | | | | | | | | 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | | | | | | | | | | | | 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 67,26 | | | 83613 | KLACID 250MG | tbl obd 14x250mg | ABB | CH | | | | | 83614 | KLACID 250MG | tbl obd 10x250mg | ABB | CH | | | | | 83615 | KLACID 250MG | tbl obd 10x250mg | ABB | I | | | | | 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 77,82 | | | 80481 | KLACID 125MG/5ML | gra sus 1x100ml | ABB | I | | | | | 53800 | KLACID 250MG/5ML | gra sus 1x100ml | ABB | I | | | | | 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 88,57 | | | 96819 | SUMAMED | tbl 6x125mg | PLI | CHO | | | | | 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 96,24 | | | 96812 | SUMAMED FORTE | sir 20ml 200mg/5ml | PLI | CHO | | | | | 96811 | SUMAMED | sir 20ml 100mg/5ml | PLI | CHO | | | | | 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 67,26 | | | | | | | | | | | | 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 87,88 | | | 93590 | SUMAMED | cps 6x250mg | PLI | CHO | | | | | 96813 | SUMAMED | tbl 3x500mg | PLI | CHO | | | | | 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | | | 261 | J01FA | makrolidová antibiotika | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 910,47 | K | | 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB | | | | | 261.2 | J01FA02 | spiramycin | parent. | 3 | GM | 1249,88 | K | | 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 65,25 | | | 91193 | DALACIN C | cps 100x150mg | UPJ | B | | | | | 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | | | | | 03365 | DALACIN C | cps 16x150mg | UPJ | B | | | | | 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | | | | | 83458 | DALACIN C | cps 16x300mg | UPJ | B | | | | | 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 160,62 | | | | | | | | | | | | 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB | | 91997 | NELOREN | cps 16x500mg | LEK | SLO | | | | | 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB | | 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 665,19 | U/ATB | | 97878 | KLIMICIN I.V. A I.M. | inj 10x2ml/300mg | LEK | SLO | | | | | 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 645,79 | U/ATB | | | | | | | | | | | 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB | | 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY | | | | | 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY | | | | | 264 | J01GA | streptomycin a jeho deriváty | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 85,05 | | | 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | | 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U | | | | | | | | | | | 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U | | | | | | | | | | | 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U | | 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO | | | | | 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U | | 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO | | | | | 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB | | | | | | | | | | | 265.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 152,06 | U/ATB | | | | | | | | | | | 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB | | | | | | | | | | | 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB | | 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR | | | | | 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB | | 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR | | | | | 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB | | | | | | | | | | | 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB | | | | | | | | | | | 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB | | | | | | | | | | | 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB | | 266 | J01MA | fluorované chinolony | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

K léčbě sparfloxacinem a trovafloxacinem je třeba konzultace a schválení antibiotického střediska.

• 1. Krátkodobou léčbu ordinuje gynekolog nebo dermatolog na základě kultivačního nebo mikroskopického vyšetření:

• a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika

• b) recidivy vaginálních mykóz

• 1. Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog:

• a) systémové mykózy u imunokompromitovaných pacientů

• b) těžké formy slizničních a kožních mykóz vyvolaných kandidami nebo dermatofyty na základě kultivačního nebo mikroskopického vyšetření

• c) těžké formy nehtových mykóz (itrakonazol), platí-li alespoň jedna z následujících podmínek:

□ postižení celé nehtové ploténky

□ postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem

□ postižení nehtu palce dolní končetiny

Podmínkou zahájení léčby ad c) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.

• d) profylakticky u imunokompromitovaných pacientů nebo u pacientů před provedením transplantace

• e) itrakonazol tekuté lékové formy - léčba orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů

Terapeuticky: těžké, život ohrožující systémové mykózy.

Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.

Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.

Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:

• a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,

• b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),

• c) léčba herpes zoster při lokalizaci v obličeji,

• d) profylaxe po alogenní transplantaci kostní dřeně.

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin,

nelfinavir a lamivudin) indikuje infekcionista pracující v AIDS centrech.

Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

• a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,

• b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,

• c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.

Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:

• a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,

• b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),

• c) léčba herpes zoster při lokalizaci v obličeji,

• d) profylaxe po alogenní transplantaci kostní dřeně.

Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.

Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir a lamivudin) indikuje infekcionista pracující v AIDS centrech.

Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:

• a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,

• b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,

• c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.

Sérum proti stafylokokovým infekcím ordinuje lékař ke komplexní léčbě těžkých stafylokokových infekcí.

Sérum proti záškrtu ordinuje infekcionista nebo pediatr ke komplexní léčbě záškrtu.

Sérum proti hadímu jedu ordinuje lékař k léčbě uštknutí zmijí obecnou.

Sérum proti botulismu ordinuje lékař ke komplexní léčbě botulismu.

Sérum proti plynaté sněti ordinuje infekcionista nebo specialista chirurgických oborů k profylaxi a terapii klostridiových infekcí.

Sérum proti vzteklině ordinuje infekcionista k profylaxi nebo terapii vztekliny.

Léčbu imunoglobuliny proti nešťovicím a pásovému oparu ordinuje infekcionista, onkolog, hematolog a pediatr:

• a) neočkované těhotné ženy,

• b) novorozenec po kontaktu s varicellou,

• c) imunokomprimovaný pacient po kontaktu s varicellou,

• d) varicelózní primární pneumonitis.

Léčbu imunoglobulinem proti cytomegalovirové infekci ordinuje infekcionista, onkolog, hematolog nebo pediatr:

• a) novorozenec s prokázanou cytomegalovirovou infekcí,

• b) generalizovaná cytomegalovirová infekce u imunokomprimovaných pacientů,

• c) profylaxe cytomegalovirových infekcí u transplantovaných pacientů při pozitivitě dárce nebo příjemce. Imunoglobulin proti cytomegalovirové infekci je hrazen dle symbolu U.

Imunoglobulin proti tetanu je hrazen dle symbolu B.

Fotemustin - léčba generalizovaného maligního melanomu. Léčbu ordinuje onkolog pouze na pracovištích se speciálním smluvním vztahem se zdravotními pojišťovnami.